[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339042-105":59,"doc-detail-339042-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","the-prognostic-value-and-potential-immunotherapeutic-efficacy-of-acvr1-in-treating-gastric-cancer","The prognostic value and potential immunotherapeutic efficacy of ACVR1 in treating gastric cancer","","The study investigates the expression of activin A receptor type-1 (ACVR1) in gastric cancer and evaluates its clinical significance. Analyses using public cancer datasets and TCGA data assess ACVR1 levels, prognostic associations, and clinicopathological correlations, supported by immunohistochemistry at the protein level. Results connect elevated ACVR1 with advanced tumor features, poor survival, and suppressive immune cells and pathways. Findings suggest ACVR1 as an independent prognostic factor and a potential immunotherapy target via immune microenvironment and checkpoint-related mechanisms.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-prognostic-value-and-potential-immunotherapeutic-efficacy-of-acvr1-in-treating-gastric-cancer/339042/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-prognostic-value-and-potential-immunotherapeutic-efficacy-of-acvr1-in-treating-gastric-cancer/339042.png","ImageObject",300,407,{"name":92,"@type":93},"Finn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":19},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main goal of the study on ACVR1 in gastric cancer?","Question",{"text":112,"@type":113},"To explore ACVR1 expression in gastric cancer, determine its clinical significance, and clarify its relationship with the tumor microenvironment for prognosis, while identifying new immunotherapy targets.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the study evaluate ACVR1 expression and its clinical relevance?",{"text":117,"@type":113},"ACVR1 was selected from public datasets, its expression and prognostic value were analyzed using TCGA, and immunohistochemistry experiments assessed protein-level expression in gastric cancer tissues.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the study find about the prognostic impact of high ACVR1 expression?",{"text":121,"@type":113},"Higher ACVR1 expression was associated with advanced clinicopathological features and poorer prognosis, and increased ACVR1 served as an independent prognostic factor for survival.",{"name":123,"@type":110,"acceptedAnswer":124},"How is ACVR1 linked to immunotherapy potential according to the results?",{"text":125,"@type":113},"ACVR1 showed strong relationships with suppressive immune cells and pathways, with findings suggesting an antitumor immune effect that promotes gastric cancer progression and leads to poor immunotherapy outcomes.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},339042,1792247930,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":19,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},34359740700684,"https://ap-avatar.wpscdn.com/avatar/1f400023980c374ae676?_k=1777273430885731487","The prognostic value and potential immunotherapeutic efficacy of ACVR1 in treating gastric cancer  \nHui Zhang1\\# ^, Ruiqi Liu2\\#, Yanrong Chen 1, Ruicong Ma 1, Qiang Xue 1, Arvind Sahu3, Xiaodi Yan 1* , Hongmei Gu1*  \n1Department of Radiation Oncology, Affiliated Hospital of Nantong University, Nantong, China; 2Department of Clinical Medicine, Medical College, Nantong University, Nantong, China; 3Department of Oncology, Goulburn Valley Health, Victoria, Australia  \nContributions: (I) Conception and design: H Zhang; (II) Administrative support: H Gu; (III) Provision of study materials or patients: R Liu, X Yan;  \n(IV) Collection and assembly of data: Y Chen, R Ma; (V) Data analysis and interpretation: Q Xue; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors.  \n\\#These authors contributed equally to this work as co-first authors.  \n*These authors contributed equally to this work as co-corresponding authors.  \nCorrespondence to: Hongmei Gu, MD; Xiaodi Yan, MD. Department of Radiation Oncology, Affiliated Hospital of Nantong University, 20 Xisi Road, Nantong 226000, China. Email: [g.hm01@163.com](g.hm01@163.com); [kristyyxd927@126.com](kristyyxd927@126.com).  \nBackground: The discovery of biomarkers has facilitated the treatment of cancer. At present, the relationship between activin A receptor type-1 (ACVR1) and gastric cancer is gradually discovered. The aim of this study was to explore the expression of ACVR1 in gastric cancer and its clinical significance, to study the relationship between ACVR1 and tumor microenvironment (TME) for the prognosis of gastric cancer,  \nand to further identify new targets for immunotherapy in gastric cancer.  \nMethods: ACVR1 was first selected as a study gene according to several cancer and gastric cancer public datasets. Its pancancer expression was explored using the UCSC Xena database. The expression level, prognosis, and clinicopathological features ofACVR1 in gastric cancer were analyzed using The Cancer Genome Atlas (TCGA) database. Immunohistochemistry (IHC)-based experiments were conducted to study the expression of ACVR1 at the protein level. The IHC data were analyzed for correlations between ACVR1 expression and various clinicopathological factors and prognosis. The correlation of this gene with the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway, immune infiltration, immune checkpoints, drug therapy, tumor mutation burden (TMB), microsatellite instability (MSI), and mismatch repair (MMR)  \nsystem was analyzed using R software.  \nResults: TCGA data showed that the expression of ACVR1 was higher in gastric cancer tissues than in paracancerous tissues. Moreover, the IHC experiments indicated that ACVR1 was upregulated in gastric cancer tissues at the protein level. Both univariate Cox and multivariate Cox results showed that the increase of ACVR1 was closely associated with tumor stage, size, lymph node metastasis, and age. High ACVR1 expression was linked to a poor prognosis of gastric cancer. The results also revealed that ACVR1 was closely related to suppressive immune cells and pathways. Analyses of immune checkpoints, antitumor drug, TMB, and immune microenvironment indicated that ACVR1 had an antitumor immune effect, promoting gastric  \ncancer development and leading to poor immunotherapy.  \nConclusions: High ACVR1 expression can be used as an independent prognostic factor to predict the prognostic survival of patients with gastric cancer. ACVR1 expression in gastric cancer tissues was significantly correlated with immune infiltration and may thus serve as a potential therapeutic target for  \ngastric cancer immunotherapy.  \nKeywords: Gastric cancer; activin A receptor type-1 (ACVR1); immune microenvironment; immune checkpoints;  \nantitumor drugs  \n^ ORCID: 0009-0003-0791-5430.  \n© Journal of Gastrointestinal Oncology. All rights reserved. J Gastrointest Oncol 2024;15(1):63-85 | [https://dx.doi.org/10.21037/jgo-23-984](https://dx.doi.org/10.","cbCaicRRgyLAUoqz","https://ap.wps.com/l/cbCaicRRgyLAUoqz","pdf",6842282,23,"English","# Introduction\n## Methods\n## Results\n## Conclusions\n## Key findings","[{\"question\":\"What was the main goal of the study on ACVR1 in gastric cancer?\",\"answer\":\"To explore ACVR1 expression in gastric cancer, determine its clinical significance, and clarify its relationship with the tumor microenvironment for prognosis, while identifying new immunotherapy targets.\"},{\"question\":\"How did the study evaluate ACVR1 expression and its clinical relevance?\",\"answer\":\"ACVR1 was selected from public datasets, its expression and prognostic value were analyzed using TCGA, and immunohistochemistry experiments assessed protein-level expression in gastric cancer tissues.\"},{\"question\":\"What did the study find about the prognostic impact of high ACVR1 expression?\",\"answer\":\"Higher ACVR1 expression was associated with advanced clinicopathological features and poorer prognosis, and increased ACVR1 served as an independent prognostic factor for survival.\"},{\"question\":\"How is ACVR1 linked to immunotherapy potential according to the results?\",\"answer\":\"ACVR1 showed strong relationships with suppressive immune cells and pathways, with findings suggesting an antitumor immune effect that promotes gastric cancer progression and leads to poor immunotherapy outcomes.\"}]","The prognostic value and potential immunotherapeutic efficacy of ACVR1 in treating gastric cancer | PDF",1790027471,58,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e50743cafeb3e0bca24f58111145749b.webp",983,1287,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ea0b1452b327cedc2f28063af7921718.webp",982,1286,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/777b34621438562a142114270e3950f9.webp",981,1284,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/684081c82c1e043f04a44438749cdbf2.webp",980,1283]